Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

MTA1, a transcriptional activator of breast cancer amplified sequence 3

Författare

  • AE Gururaj
  • RR Singh
  • SK Rayala
  • Caroline Wigerup
  • P den Hollander
  • H Zhang
  • S Balasenthil
  • AH Talukder
  • Göran Landberg
  • R Kumar

Summary, in English

Here we define a function of metastasis-associated protein 1 (MTA1), a presumed corepressor of estrogen receptor alpha (ER alpha), as a transcriptional activator of Breast Cancer Amplified Sequence 3 (BCAS3), a gene amplified and overexpressed in breast cancers. We identified BCAS3 as a MTA1 chromatin target in a functional genomic screen. MTA1 stimulation of BCAS3 transcription required ERa and involved a functional ERE half-site in BCAS3. Furthermore, we discovered that MTA1 is acetylated on lysine 626, and that this acetylation is necessary for a productive transcriptional recruitment of RNA polymerase 11 complex to the BCAS3 enhancer sequence. BCAS3 expression was elevated in mammary tumors from MTA1 transgenic mice and 60% of the human breast tumors, and correlated with the coexpression of MTA1 as well as with tumor grade and proliferation of primary breast tumor samples. These findings reveal a previously unrecognized function of MTA1 in stimulating BCAS3 expression and suggest an important role for MTA1-BCAS3 pathway in promoting cancerous phenotypes in breast tumor cells.

Avdelning/ar

Publiceringsår

2006

Språk

Engelska

Sidor

6670-6675

Publikation/Tidskrift/Serie

Proceedings of the National Academy of Sciences

Volym

103

Issue

17

Dokumenttyp

Artikel i tidskrift

Förlag

National Academy of Sciences

Ämne

  • Cell and Molecular Biology
  • Cancer and Oncology

Nyckelord

  • estrogen receptor
  • BCAS3
  • coactivator

Status

Published

Forskningsgrupp

  • Pathology, Malmö

ISBN/ISSN/Övrigt

  • ISSN: 1091-6490